WELLINGHOFF DARRYL (Chief Commercial Officer) received a stock award from LA JOLLA PHARMACEUTICAL CO
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/17/2020ACC: 0000920465-20-000050
Officer· Chief Commercial Officer
Since Mar 2019
+68.00
Net shares
Net buyer
$190.74
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
68.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34.00
Price / share
$5.61
Trade value
$190.74
% of position
0.4%
4/15/2020
9.47K→9.50K
Total
Net shares
+34.00
Net value
$190.74
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2020 | A · Award | +34.00 | $5.61 | $190.74 | 0.4% | 9.47K | 9.50K |
| Total | +34.00 | $190.74 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
34.00 shares
Shares
+34.00
Strike price
6.6
Held after
34.00
Exercisable
—
4/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock34.00 shares | 4/15/2020 | A · Award | +34.00 | 6.6 | — | 34.00 |